Abstract
This chapter deals with the employment of human-induced pluripotent stem cells (hiPSCs) as a candidate to differentiate into mesenchymal stem cells (MSCs). This would enable to help establish a regular source of human MSCs with the aim of avoiding the problems associated with procuring the MSCs either from different healthy individuals or patients, limited extraction potentials, batch-to-batch variations or from diverse sources such as bone marrow or adipose tissue. The procedures described herein allow for a guided and ensured approach for the regular maintenance of hiPSCs and their subsequent differentiation into MSCs using the prescribed medium. Subsequently, an easy protocol for the successive isolation and purification of the hiPSC-differentiated MSCs is outlined, which is carried out through passaging and can be further sorted through flow cytometry. Further, the maintenance and expansion of the resultant hiPSC-differentiated MSCs using appropriate characterization techniques, i.e., Reverse-transcription PCR and immunostaining is also elaborated. The course of action has been deliberated keeping in mind the awareness and the requisites available to even beginner researchers who mostly have access to regular consumables and medium components found in the general laboratory.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Sparman M, Dighe V, Sritanaudomchai H, Ma H, Ramsey C, Pedersen D, Clepper L, Nighot P, Wolf D, Hennebold J, Mitalipov S (2009) Epigenetic reprogramming by somatic cell nuclear transfer in primates. Stem Cells 27(6):1255–1264. doi:10.1002/stem.60
Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4):663–676. doi:10.1016/j.cell.2006.07.024
Shi Z, Zhang J, Chen S, Li Y, Lei X, Qiao H, Zhu Q, Hu B, Zhou Q, Jiao J (2016) Conversion of fibroblasts to parvalbumin neurons by one transcription factor, Ascl1, and the chemical compound forskolin. J Biol Chem. doi:10.1074/jbc.M115.709808
Kawaguchi M, Kitajima K, Kanokoda M, Suzuki H, Miyashita K, Nakajima M, Nuriya H, Kasahara K, Hara T (2016) Efficient production of platelets from mouse embryonic stem cells by enforced expression of Gata2 in late hemogenic endothelial cells. Biochem Biophys Res Commun. doi:10.1016/j.bbrc.2016.04.140
Liu T, Li Q, Wang S, Chen C, Zheng J (2016) Transplantation of ovarian granulosalike cells derived from human induced pluripotent stem cells for the treatment of murine premature ovarian failure. Mol Med Rep. doi:10.3892/mmr.2016.5191
Sequiera GL, Mehta A, Ooi TH, Shim W (2013) Ontogenic development of cardiomyocytes derived from transgene-free human induced pluripotent stem cells and its homology with human heart. Life Sci 92(1):63–71. doi:10.1016/j.lfs.2012.10.020
Ramos-Mejia V, Munoz-Lopez M, Garcia-Perez JL, Menendez P (2010) iPSC lines that do not silence the expression of the ectopic reprogramming factors may display enhanced propensity to genomic instability. Cell Res 20(10):1092–1095. doi:10.1038/cr.2010.125
Bilic J, Izpisua Belmonte JC (2012) Concise review: induced pluripotent stem cells versus embryonic stem cells: close enough or yet too far apart? Stem Cells 30(1):33–41. doi:10.1002/stem.700
Martins-Taylor K, Xu RH (2012) Concise review: genomic stability of human induced pluripotent stem cells. Stem Cells 30(1):22–27. doi:10.1002/stem.705
Lalu MM, McIntyre L, Pugliese C, Fergusson D, Winston BW, Marshall JC, Granton J, Stewart DJ (2012) Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials. PLoS One 7(10):e47559. doi:10.1371/journal.pone.0047559
Padda J, Sequiera GL, Sareen N, Dhingra S (2015) Stem cell therapy for cardiac regeneration: hits and misses. Can J Physiol Pharmacol 93(10):835–841. doi:10.1139/cjpp-2014-0468
Liang G, Zhang Y (2013) Embryonic stem cell and induced pluripotent stem cell: an epigenetic perspective. Cell Res 23(1):49–69. doi:10.1038/cr.2012.175
Mahmoudi S, Brunet A (2012) Aging and reprogramming: a two-way street. Curr Opin Cell Biol 24(6):744–756. doi:10.1016/j.ceb.2012.10.004
Lian Q, Zhang Y, Zhang J, Zhang HK, Wu X, Lam FF, Kang S, Xia JC, Lai WH, Au KW, Chow YY, Siu CW, Lee CN, Tse HF (2010) Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice. Circulation 121(9):1113–1123. doi:10.1161/CIRCULATIONAHA.109.898312
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Sequiera, G.L., Saravanan, S., Dhingra, S. (2017). Human-Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells as an Individual-Specific and Renewable Source of Adult Stem Cells. In: Di Nardo, P., Dhingra, S., Singla, D. (eds) Adult Stem Cells. Methods in Molecular Biology, vol 1553. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6756-8_14
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6756-8_14
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6754-4
Online ISBN: 978-1-4939-6756-8
eBook Packages: Springer Protocols